On August 6, Registrar Corp is heading to Miami, Florida to host a seminar about the U.S. Food and Drug Administration (FDA) Unique Device Identification (UDI) regulation at FIME’s 24th Annual Education Conference.
In September 2013, FDA released a final rule requiring most domestic and foreign medical devices distributed in the U.S. to carry a UDI. Along with this, the labeler of each medical device carrying a UDI must submit information about the device to the Global Unique Device Identification Database (GUDID), a labeler being any person who applies a label to a medical device intended to be commercially distributed in the U.S. without any further modifications to the labeling. Join Registrar Corp at the Miami Convention Center in room D231 to learn more about UDI regulation and its impact on regulated industry. Register for the conference at: http://www.fimeshow.com/.
Registrar Corp is an FDA consulting firm that helps companies comply with FDA requirements. For more information about the seminar or other FDA medical device regulations, contact Registrar Corp at 1-757-224-0177 or receive online Live Help from our regulatory specialists: https://www.registrarcorp.com/livehelp.